Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe phrase "Wegovy 3ml" usually comes from people reading the label on their pen and wondering what the volume means for their dose or how long the pen lasts. Each Wegovy pre-filled pen holds 3ml of solution — that volume is fixed across all dose strengths and contains a single weekly injection. The amount of semaglutide inside that 3ml varies by strength, which is the figure that matters clinically. Wegovy is a prescription-only medicine; a GPhC-registered prescriber determines which strength is right for you following a clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you pick up a Wegovy pen and spot "3ml" on the label, you are reading the fill volume of the cartridge, not the dose. Novo Nordisk manufactures all pens in the Wegovy range with that same 3ml fill. The dose (the quantity of semaglutide your body receives) is expressed in milligrams, and that number changes as your prescriber moves you through the titration schedule.
Think of it this way: two pens, both 3ml, could contain very different amounts of active medicine. The 0.25mg starter pen and the 2.4mg maintenance pen are both 3ml; the concentration of semaglutide per millilitre differs between them. So if you are comparing pens or checking what arrived in the post, the number to look up in the Patient Information Leaflet is the milligram strength, not the volume. Wegovy's full licensed profile in the UK, including the titration pathway, is explained in detail if you want the wider picture.
This distinction matters practically: it means you cannot infer from "3ml" alone what dose you are taking, whether your pen is a starter or a maintenance strength, or whether a pen from another provider is equivalent to yours. If you want to explore how 3ml semaglutide is supplied and what that format covers, that page sets out the specifics clearly. The strength is printed separately on the label and on the outer carton, always cross-reference both.
The Wegovy titration schedule runs from a 0.25mg starting dose, progressing through 0.5mg, 1.0mg and 1.7mg, to the 2.4mg standard maintenance dose, with each step typically lasting around four weeks under prescriber guidance. Semaglutide's mechanism and clinical evidence sit behind every step: slower gastric emptying, reduced appetite signalling, and the GLP-1 receptor pathway that the medicine activates.
A question our prescribers hear most weeks is whether a patient can speed up the schedule if they feel ready. The answer is always that timing is a clinical decision, not one to make from the volume on the barrel. Moving too quickly tends to amplify gastrointestinal side effects (nausea, loose stools, reflux) which are already the most commonly reported effects in this medicine class, as the NHS patient information for semaglutide documents. The titration exists precisely to let your system adjust.
In April 2026 the MHRA approved a dedicated single-dose 7.2mg pen, which also uses a pre-filled format; the starting dose for that route remains 0.25mg, titrated upward by your prescriber. If you want to understand how Wegovy volumes and concentrations relate across the pen range, that comparison page sets it out clearly. Never adjust your own dose or timing without speaking to your prescriber first.
Because Wegovy is widely discussed online, fake pens have entered circulation. The MHRA has issued repeated public warnings about counterfeit weight-loss injections sold through social media and unverified websites, in some seizures, fake pens were found to contain insulin rather than semaglutide, which caused hospitalisations. The volume printed on the label tells you nothing about whether a pen is genuine; only the supply chain does.
The safe route is a prescription from a GPhC-registered pharmacy that sources through the licensed UK supply chain. You can verify any online pharmacy on the GPhC's public register before you hand over any personal details. Pens offered without a prior clinical assessment, at prices noticeably below the current private market, or through social-media sellers are red flags regardless of what the label says.
If you want to understand what private treatment currently costs and why the range varies, the Wegovy cost page walks through the market context without hiding the reality of pricing since Novo Nordisk adjusted its UK list prices.
In practice, you do not measure or draw up anything. The pen is pre-filled and pre-set to your prescribed strength; you press the injector against the skin of your abdomen, thigh or upper arm, press the button, and the full dose is delivered in a single click. The 3ml fill is the manufacturer's cartridge design, sized to allow the auto-injector mechanism to function reliably, not a variable you interact with.
Store the pen in a refrigerator between 2°C and 8°C. For the exact room-temperature window if you are travelling or the fridge is unavailable, consult the Patient Information Leaflet rather than any third-party source, including this page. Queries about specific volumes like 1ml arise for similar reasons, people reading their pen and trying to make sense of what the numbers mean. The milligram dose on the label is always the figure to track.
If you have questions about Wegovy, speaking to our prescribers through a free consultation is the right next step. They review every application personally, the same day, and can confirm which strength is appropriate for your circumstances.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.